Bitcoin's price fell from $126,000 to $60,000 through derivatives trading, not spot selling.
Bitcoin’s value plunged from $126,000 to $60,000 in four months, driven by synthetic derivatives trading and leverage cascades, not major news, impacting global markets.
This decline highlights vulnerabilities in derivatives markets, causing concern over regulatory oversight and institutional stability in the cryptocurrency ecosystem.
Bitcoin (BTC) experienced a drastic price decline from approximately $126,000 to $60,000 over a four-month period, largely attributed to synthetic derivatives trading. Observers noted the absence of major news events or spot selling as catalysts. Bull Theory, an active market analyst, stated,
“Bitcoin has now crashed -53% in just JST +0.00% 120 days without any major negative news or event and this is not normal.”
The crash primarily affected Bitcoin with negligible mentions of Ethereum ETH +0.00% or other altcoins.
On-chain data demonstrated a complex market response, with small holders accumulating BTC while mid-sized holders distributed slightly. The BTC Puell Multiple at 0.6 indicated statistical cheapness, suggesting potential long-term recovery. Despite the turmoil, no official comments or strategy shifts from exchange leaders, such as Binance’s CZ, were reported. The crash is described as mechanical rather than a classic cycle driven by on-chain spot flows, highlighting the derivatives’ role.
This price fluctuation underscores derivatives trading influences in contrast to spot selling dynamics. While retail investor panic was notably absent, the potential for regulatory scrutiny exists. Policymakers and analysts may reconsider current frameworks to address derivative-related volatility. This situation highlights the evolving nature of cryptocurrency markets and the importance of monitoring synthetic instruments’ impact.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
Crypto prices
More
